tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Akash Tewari, 138 are a BUY (77.97%), 34 are a HOLD (19.21%), 5 are a SELL (2.82%).
Analyst Akash Tewari, currently employed at JEFFERIES, carries an average stock price target met ratio of 48.75% that have a potential upside of 32.33% achieved within 244 days.
Akash Tewari’s has documented 338 price targets and ratings displayed on 33 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BNTX, BioNTech SE at 10-Mar-2026.
Analyst best performing recommendations are on ARVN (ARVINAS).
The best stock recommendation documented was for ARVN (ARVINAS) at 6/21/2022. The price target of $42 was fulfilled within 2 days with a profit of $3.11 (8%) receiving and performance score of 39.98.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 19-Dec-2022
$43
$8.16 (23.42%)
$45
16 days ago
(24-Mar-2026)
5/16 (31.25%)
$14.6 (51.41%)
165
Buy Since 03-Sep-2025
$43
$8.16 (23.42%)
$37
1 months 14 days ago
(26-Feb-2026)
0/4 (0%)
$12.27 (39.93%)
Hold Since 14-Oct-2022
$34
$-0.84 (-2.41%)
$34
1 months 20 days ago
(20-Feb-2026)
13/15 (86.67%)
$2.09 (6.55%)
74
Buy Since 11-Feb-2025
$45
$10.16 (29.16%)
$52
4 months 27 days ago
(13-Nov-2025)
0/3 (0%)
$13.99 (45.11%)
Buy Since 28-May-2025
$44
$9.16 (26.29%)
$45
5 months 11 days ago
(29-Oct-2025)
0/4 (0%)
$12.55 (39.90%)
Which stock is Akash Tewari is most bullish on?
Which stock is Akash Tewari is most reserved on?
What Year was the first public recommendation made by Akash Tewari?
